Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Tsakiris

Showing results (141-150 of 159) with videos related to

Pageof 16
Sort By:
European Journal of Haematology|March 17, 2009
Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortalityNathan Cantoni, Maja Weisser, Andreas Buser, et al.
Trials|January 20, 2023
Enhancement of the haemostatic effect of platelets in the presence of high normal concentrations of von Willebrand factor for critically ill patients needing platelet transfusion-a protocol for the will-plate randomised controlled trialGoetz Herrmann, Andrea Blum, Daniel Bolliger, et al.
Blood Advances|August 4, 2025
Outcomes of Patients with Suspected Heparin-Induced Thrombocytopenia in a Contemporary Multicenter CohortHenning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, et al.
Cytotherapy|December 3, 2020
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myelomaAstrid Tschan-Plessl, Christian P Kalberer, Ronja Wieboldt, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2024
The dynamic range of immunoassays for heparin-induced thrombocytopeniaHenning Nilius, Samra Naas, Jan-Dirk Studt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2023
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT studyAngelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, et al.
Swiss Medical Weekly|April 25, 2020
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in SwitzerlandLorenzo Alberio, Anne Angelillo-Scherrer, Lars Asmis, et al.
Thrombosis and Haemostasis|November 7, 2014
Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutationsKirstin Sandrock-Lang, Johannes Oldenburg, Verena Wiegering, et al.
Blood Advances|April 8, 2024
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopeniaHenning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, et al.
Swiss Medical Weekly|December 18, 2020
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumabPierre Fontana, Lorenzo Alberio, Manuela Albisetti, et al.
Pageof 16

Showing results (141-150 of 159) with videos related to

Sort By:
Pageof 16
European Journal of Haematology|March 17, 2009
Infection prevention strategies in a stem cell transplant unit: impact of change of care in isolation practice and routine use of high dose intravenous immunoglobulins on infectious complications and transplant related mortalityNathan Cantoni, Maja Weisser, Andreas Buser, et al.
Trials|January 20, 2023
Enhancement of the haemostatic effect of platelets in the presence of high normal concentrations of von Willebrand factor for critically ill patients needing platelet transfusion-a protocol for the will-plate randomised controlled trialGoetz Herrmann, Andrea Blum, Daniel Bolliger, et al.
Blood Advances|August 4, 2025
Outcomes of Patients with Suspected Heparin-Induced Thrombocytopenia in a Contemporary Multicenter CohortHenning Nilius, Ekaterina Sinitsa, Jan-Dirk Studt, et al.
Cytotherapy|December 3, 2020
Cellular immunotherapy with multiple infusions of in vitro-expanded haploidentical natural killer cells after autologous transplantation for patients with plasma cell myelomaAstrid Tschan-Plessl, Christian P Kalberer, Ronja Wieboldt, et al.
Journal of Thrombosis and Haemostasis : JTH|November 13, 2024
The dynamic range of immunoassays for heparin-induced thrombocytopeniaHenning Nilius, Samra Naas, Jan-Dirk Studt, et al.
Journal of Thrombosis and Haemostasis : JTH|May 29, 2023
Limited concordance of heparin/platelet factor 4 antibody assays for the diagnosis of heparin-induced thrombocytopenia: an analysis of the TORADI-HIT studyAngelika Hammerer-Lercher, Henning Nilius, Jan-Dirk Studt, et al.
Swiss Medical Weekly|April 25, 2020
Recommendations on the use of anticoagulants for the treatment of patients with heparin-induced thrombocytopenia in SwitzerlandLorenzo Alberio, Anne Angelillo-Scherrer, Lars Asmis, et al.
Thrombosis and Haemostasis|November 7, 2014
Characterisation of patients with Glanzmann thrombasthenia and identification of 17 novel mutationsKirstin Sandrock-Lang, Johannes Oldenburg, Verena Wiegering, et al.
Blood Advances|April 8, 2024
Proteomic profiling for biomarker discovery in heparin-induced thrombocytopeniaHenning Nilius, Hind Hamzeh-Cognasse, Janna Hastings, et al.
Swiss Medical Weekly|December 18, 2020
Management of bleeding events and invasive procedures in patients with haemophilia A without inhibitors treated with emicizumabPierre Fontana, Lorenzo Alberio, Manuela Albisetti, et al.
Pageof 16